FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4597718016 | Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4597719012 | Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 468730011 | Polyethylene+benzalkonium chloride 21.9/0.25% gel | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 468730011 | Polyethylene+benzalkonium chloride 21.9/0.25% gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 721612011 | Polyethylene+benzalkonium chloride 21.9/0.25% gel (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1192701013 | Polyethylene+benzalkonium chloride 21.9/0.25% gel (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1192701013 | Polyethylene+benzalkonium chloride 21.9/0.25% gel (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763187013 | Benzalkonium 2.5 microgram/mg and polyethylene 219 microgram/mg cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763188015 | Product containing precisely benzalkonium 2.5 microgram/1 milligram and polyethylene 219 microgram/1 milligram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4597718016 | Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4597719012 | Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Topical abrasive agents | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | agent cutané | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Benzalkonium chloride | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Polyethylene (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | agent anti-infectieux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Topical abrasive agent | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | forme pharmaceutique pour usage transdermique et/ou cutané | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Topical anti-infective | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing benzalkonium in topical dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Conventional release cutaneous gel (dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing polymer (product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit (attribute) | mg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit (attribute) | mg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Benzalkonium and polyethylene only product in cutaneous dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Polyethylene (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Polyethylene (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Benzalkonium (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator value | 2.5 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Benzalkonium (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator value | 219 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit (attribute) | g | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit (attribute) | g | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets